Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00258583 · ClinicalTrials.gov registry record
Dorothy P. and Richard P. Simmons Center for ILD Research Registry
A clinical trial of Lung Diseases, Interstitial, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT00258583: Recruiting study of Lung Diseases, Interstitial, sponsored by University of Pittsburgh.
NCT00258583 is a study of Lung Diseases, Interstitial that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 5,000 participants, below the 12,009-participant average among 10 other Lung Diseases, Interstitial trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00258583, a study of Lung Diseases, Interstitial, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to place past, current, and future medical record information into the UPMC Simmons Center for Interstitial Lung Disease Research Registry.
Conditions Studied
Study Locations (1)
Pennsylvania
- Michelle F MacPherson - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2003-10 |
| Est. Completion | 2035-07 |
What NCT00258583 shows while recruiting
NCT00258583 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, below the 12,009-participant average among 10 other Lung Diseases, Interstitial trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Lung Diseases, Interstitial appearing as the primary indexed condition, and to 0 interventions.
NCT00258583 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00258583 about?
NCT00258583 is a clinical study titled "Dorothy P. and Richard P. Simmons Center for ILD Research Registry". The purpose of this study is to place past, current, and future medical record information into the UPMC Simmons Center for Interstitial Lung Disease Research Registry.
What is the current status of trial NCT00258583?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2003-10. Estimated completion is 2035-07.
What conditions does trial NCT00258583 study?
This clinical trial studies the following conditions: Lung Diseases, Interstitial.
Who is sponsoring clinical trial NCT00258583?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00258583 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Diseases, Interstitial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00258583's enrollment target sits among peer trials
5,000 2nd of 10 the highest of 10 other Lung Diseases, Interstitial trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Diseases, Interstitial trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RECRUITING · Phase 3
-
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
RECRUITING · Phase 2
-
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
RECRUITING · Phase 1
-
Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation
RECRUITING · NA
-
Cough Capture as a Portal Into the Lung
RECRUITING
-
Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia